Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201303138 Principal Investigator: Baggstrom, Maria
Title: A Randomized, Open-Label Phase 2 study of EC145 single-agent and the combination of EC145 and Docetaxel versus Docetaxel alone in Participants with folate-receptor positive (FR++) second line NSCLC
Phase: II Disease Site: Lung
Participating Site(s):
 
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to test how well EC145 given alone or in combination with docetaxel can treat patients with non-small cell lung cancer (NSCLC) that has progressed or
recurred (came back) after prior therapy.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)